Cargando…
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
BACKGROUND: Cystic fibrosis (CF) is a rare, inherited, life-limiting condition predominantly affecting the lungs, for which there is no cure. The disease is characterized by recurrent pulmonary exacerbations (PEx), which are thought to drive progressive lung damage. Management of these episodes is c...
Autores principales: | Schultz, Andre, McLeod, Charlie, Berry, Scott, Marsh, Julie, McKenzie, Anne, Messer, Mitch, Wood, Jamie, Saville, Ben, Jaffe, Adam, Ranganathan, Sarath, Stick, Steve, Wark, Peter, Webb, Steve, Snelling, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031862/ https://www.ncbi.nlm.nih.gov/pubmed/36949472 http://dx.doi.org/10.1186/s13063-023-07076-8 |
Ejemplares similares
-
Protocol for establishing a core outcome set for evaluation in studies of pulmonary exacerbations in people with cystic fibrosis
por: McLeod, Charlie, et al.
Publicado: (2022) -
Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis
por: Schultz, Andre, et al.
Publicado: (2019) -
Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012) -
Is the Improvement of CF Patients, Hospitalized for Pulmonary Exacerbation, Correlated to a Decrease in Bacterial Load?
por: Deschaght, Pieter, et al.
Publicado: (2013) -
Choosing primary endpoints for clinical trials of health care interventions
por: McLeod, Charlie, et al.
Publicado: (2019)